Phase 1b investigator initiated trial of combination therapy of Metformin and Nivolumab in participants with advanced or recurrent solid cancer.
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Nivolumab (Primary) ; Metformin
- Indications Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 30 Aug 2017 Status changed from not yet recruiting to recruiting.
- 31 Jul 2017 New trial record